National Updates
CDC Panel to Vote on Pediatric MMRV and Hepatitis B Vaccine Use
The CDC is preparing for a vote on whether to change guidance for pediatric use of the combined Measles-Mumps-Rubella-Varicella (MMRV) vaccine and Hepatitis B vaccine. The advisory meeting is scheduled for September 18-19. Reuters
Texas Updates
UTSA Expands Opioid Overdose Prevention on College Campuses
The University of Texas San Antonio, in partnership with state health authorities, is launching a statewide initiative to provide free naloxone nasal spray (Narcan) and overdose response training at colleges across Texas. This effort aims to counter overdose deaths from fentanyl-laced pills among young adults. San Antonio Express-News
Austin Still Leads State in Travel-Related Dengue Cases
DSHS reports that while dengue cases statewide remain lower than last year, Austin is still the county with the highest number of travel-associated dengue cases — 31 so far in 2025. Vax-Before-Travel
Global Health Alerts
Increasing Vector-Borne Disease Threats in U.S. & Globally Due to Mosquito Resurgence
Climate change, urbanization, and increased travel are driving higher risk of mosquito-borne diseases including West Nile, dengue, chikungunya and emerging threats like Oropouche virus. Texas is already seeing increased vector surveillance. Vox
Clinical Tips for Providers
- Be ready to inform parents on any changes in the upcoming CDC vaccine guidance for MMRV and Hepatitis B.
- Ensure opioid safety training and naloxone access at universities; consider outreach in campus health centers.
- Remind patients traveling internationally of dengue prevention (mosquito bites, repellants, etc.).
- Increase vigilance for vector-borne disease symptoms (fever, rash, joint pains) especially in patients with travel exposure or residing in high mosquito activity areas.
